Paid Clinical Trials Greensboro
Discover 1,705 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
DWN12088Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Sponsor:
Daewoong Pharmaceutical Co. LTD.
Location:
Code:
NCT05389215
Conditions
Idiopathic Pulmonary Fibrosis
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
DWN12088
Placebo
TesetaxelTesetaxel as First-line Therapy for Metastatic Breast Cancer
Sponsor:
Genta Incorporated
Location:
Code:
NCT01221870
Conditions
Breast Neoplasm
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Tesetaxel once every 3 weeks
Tesetaxel once weekly
Observational StudyAn INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY to ASSESS the PERFORMANCE of the CORDIO HEARO SYSTEM
Sponsor:
Cordio Medical
Location:
Code:
NCT06378632
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 22+
Healthy Volunteers: Not accepted
Interventions
Hearo App
VixarelimabA Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease
Sponsor:
Genentech, Inc.
Location:
Code:
NCT05785624
Conditions
Idiopathic Pulmonary Fibrosis
Systemic Sclerosis With Lung Involvement
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Vixarelimab
Placebo
ExerciseThe Role of the Time of Day in the Effects of Exercise on Memory in Heathy Young Adults
Sponsor:
University of North Carolina, Greensboro
Location:
Code:
NCT04861818
Conditions
Aerobic Exercise
Cognitive Change
Eligibility Criteria
Sex: All
Age: 18 - 25
Healthy Volunteers: Accepted
Interventions
Moderate-intensity aerobic exercise
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CardioPulmonary ManagementFeasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Sponsor:
Analog Device, Inc.
Location:
Code:
NCT05650541
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CardioPumlonary Management System
CPMFeasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure ( BETA )
Sponsor:
Analog Device, Inc.
Location:
Code:
NCT06045117
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CardioPumlonary Management System (CPM)
Livmoniplimab & BudigalimabStudy to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
AbbVie
Location:
Code:
NCT06236438
Conditions
Non-Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Livmoniplimab
Budigalimab
Pembrolizumab
Pemetrexed
Cisplatin
LEVosimendanLEVosimendan to Improve Exercise Limitation in Patients with PH-HFpEF
Sponsor:
Tenax Therapeutics, Inc.
Location:
Code:
NCT05983250
Conditions
Pulmonary Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
TNX-103
Placebo
MosliciguatA Study of Mosliciguat in PH-ILD
Sponsor:
Pulmovant, Inc.
Location:
Code:
NCT06635850
Conditions
Pulmonary Hypertension
Interstitial Lung Disease
Lung Diseases
Vascular Diseases
Cardiovascular Diseases
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Mosliciguat
Dry Powder Inhaler
Placebo